PARIS, February 14 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the Chicago Athenaeum Museum of Architecture and Design has awarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposable insulin injection pen for people with type 1 and type 2 diabetes.
"LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the results of over four years of intensive development, have been designed in dialogue with patients, nurses and doctors and meet the high standards of the industry," said Paul Jansen, Global Head Medical Devices, sanofi-aventis.
"We are proud to receive this prestigious GOOD DESIGN Award for SoloSTAR(R) as a recognition of our strong commitment to people with diabetes", Gilles Lhernould, Senior Vice President Industrial Affairs sanofi-aventis added.
For some people with diabetes, self-injection can be a barrier to acceptance of insulin therapy. "SoloSTAR(R) is a marriage of sleek, handsome design styling with easy, but advanced sophisticated technology for dispensing insulin to people with diabetes," says Christian K. Narkiewicz-Laine, President Chicago Athenaeum Museum of Architecture and Design. "SoloSTAR(R) represents a design for social good and for humanitarian concerns".
When choosing a specific insulin pen for an individual patient, clinicians consider the patient's insulin regimen, lifestyle, and other factors that may affect the ability to use a particular device, such as manual dexterity and visual acuity. Therefore certain characteristics of a given insulin pen may make it preferable for patients. The outstanding design of SoloSTAR(R) using breakthrough technology contributes to making this patients' and clinicians' choice easier.
SoloSTAR(R) provides a delivery option that may be more acceptable and more convenient to use in comparison with other delivery systems, thus may promote patient compliance, which could help achieve and maintain glycemic control.
A recent survey of LANTUS(
Copyright©2008 PR Newswire.
All rights reserved